Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Share
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Nilay Patel, The Verge editor-in-chief, and Brent Thill, Jefferies analyst, join ‘TechCheck’ to discuss how the slowing digital advertising market is affecting employee treatment, what Thill is looking for from Alphabet earnings and more. 03:20 Tue, Jul 26 202212:09 PM EDT
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Mike Khouw, Optimize Advisors president, joins CNBC’s Melissa Lee and the Options Action traders to talk Lucid. 01:08 Mon, Nov 13 20236:42 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Trivariate Research CEO Adam Parker and Nicole Webb, senior vice president and financial advisor at Wealth Enhancement Group, join ‘Closing Bell’ to discuss their market outlook for 2024, expectations from the Fed, and more. 19:36 Tue, Jan 9 20243:35 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email David George, Baird senior analyst, joins ‘Fast Money’ to talk his bearish calls on banks ahead of another round of earnings. 03:38 Mon, Jan 8 20246:16 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Boeing CEO Dave Calhoun joins ‘The Exchange’ to discuss the Alaska Airlines incident, how the company is addressing this, and more. 04:00 Wed, Jan 10 20241:22 PM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email In honor of Scrabble Day, CNBC has compiled the most important numbers on the world-popular board game. Did you known approximately 150 million sets have been sold worldwide? 00:00 Mon, Apr 13 20158:00 AM EDT